CD27- B-cells produce class switched and somatically hyper-mutated antibodies during chronic HIV-1 infection

PLoS ONE

Volumn 4, Issue 5, 2009, Pages

  Cagigi, Alberto ^a   Du, Likun ^b   Dang, Linh Vu Phuong ^a   Grutzmeier, Sven ^c   Atlas, Anna ^b   Chiodi, Francesca ^a   Pan Hammarström, Qiang ^b   Nilsson, Anna ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c STOCKHOLM SÖDER HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD27 ANTIGEN; CD40 ANTIGEN; CYTIDINE DEAMINASE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; TOLL LIKE RECEPTOR 9; AICDA (ACTIVATION INDUCED CYTIDINE DEAMINASE); AICDA (ACTIVATION-INDUCED CYTIDINE DEAMINASE); HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; PRIMER DNA; TLR9 PROTEIN, HUMAN;

ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; B LYMPHOCYTE; CHRONIC DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; GENE REARRANGEMENT; GENETIC RECOMBINATION; HEAVY CHAIN; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCTION; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PROTEIN EXPRESSION; SOMATIC HYPERMUTATION; BIOSYNTHESIS; BLOOD; CASE CONTROL STUDY; ENZYMOLOGY; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; METABOLISM; NUCLEOTIDE SEQUENCE;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ANTIGENS, CD27; ANTIGENS, CD40; B-LYMPHOCYTE SUBSETS; BASE SEQUENCE; CASE-CONTROL STUDIES; CYTIDINE DEAMINASE; DNA PRIMERS; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOGLOBULIN G; LYMPHOCYTE ACTIVATION; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN; TOLL-LIKE RECEPTOR 9;

EID: 65549096705     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0005427     Document Type: Article

References (47)

1. Zinkernagel RM (2000) On immunological memory. Philos Trans R Soc Lond B Biol Sci 355: 369-371.
2. Carsetti R, Rosado MM, Wardmann H (2004) Peripheral development of B cells in mouse and man. Immunol Rev 197: 179-191.
3. Pan-Hammarstrom Q, Zhao Y, Hammarstrom L (2007) Class switch recombination: a comparison between mouse and human. Adv Immunol 93: 1-61.
4. Revy P, Buck D, le Deist F, de Villartay JP (2005) The repair of DNA damages/modifications during the maturation of the immune system: lessons from human primary immunodeficiency disorders and animal models. Adv Immunol 87:237-295.
5. Stavnezer J, Guikema JE, Schrader CE (2008) Mechanism and regulation of class switch recombination. Annu Rev Immunol 26: 261-292.
6. De Milito A (2004) B lymphocyte dysfunctions in HIV infection. Curr HIV Res 2: 11-21.
7. Agematsu K (2000) Memory B cells and CD27. Histol Histopathol 15: 573-576.
8. De Milito A, Nilsson A, Titanji K, Thorstensson R, Reizenstein E, et al. (2004) Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection. Blood 103: 2180-2186.
9. Moir S, Malaspina A, Ogwaro KM, Donoghue ET, Hallahan CW, et al. (2001) HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals. Proc Natl Acad Sci U S A 98: 10362-10367.
10. Fondere JM, Huguet MF, Macura-Biegun A, Baillat V, Ohayon V, et al. (2004) Detection and enumeration of circulating HIV-1-specific memory B cells in HIV-1-infected patients. J Acquir Immune Defic Syndr 35: 114-119.
11. De Milito A, Morch C, Sonnerborg A, Chiodi F (2001) Loss of memory (CD27) B lymphocytes in HIV-1 infection. AIDS 15: 957-964.
12. Titanji K, De Milito A, Cagigi A, Thorstensson R, Grutzmeier S, et al. (2006) Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection. Blood 108: 1580-1587.
13. Moir S, Malaspina A, Ho J, Wang W, Dipoto AC, et al. (2008) Normalization of B Cell Counts and Subpopulations after Antiretroviral Therapy in Chronic HIV Disease. J Infect Dis.
14. Titanji K, Chiodi F, Bellocco R, Schepis D, Osorio L, et al. (2005) Primary HIV-1 infection sets the stage for important B lymphocyte dysfunctions. Aids 19: 1947-1955.
15. Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, et al. (2000) Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102: 553-563.
16. Stavnezer J (1996) Immunoglobulin class switching. Curr Opin Immunol 8: 199-205.
17. Islam KB, Nilsson L, Sideras P, Hammarstrom L, Smith CI (1991) TGF-beta 1 induces germ-line transcripts of both IgA subclasses in human B lymphocytes. Int Immunol 3: 1099-1106.
18. Malisan F, Briere F, Bridon JM, Harindranath N, Mills FC, et al. (1996) Interleukin-10 induces immunoglobulin G isotype switch recombination in human CD40-activated naive B lymphocytes. J Exp Med 183: 937-947.
19. Korthauer U, Graf D, Mages HW, Briere F, Padayachee M, et al. (1993) Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 361: 539-541.
20. He B, Qiao X, Klasse PJ, Chiu A, Chadburn A, et al. (2006) HIV-1 envelope triggers polyclonal Ig class switch recombination through a CD40-independent mechanism involving BAFF and C-type lectin receptors. J Immunol 176: 3931-3941.
21. Qiao X, He B, Chiu A, Knowles DM, Chadburn A, et al. (2006) Human Immunodeficiency virus 1 Nef suppresses CD40-dependent immunoglobulin class switching in bystander B cells. Nat Immunol 7: 302-310.
22. Wen S, Felley CP, Bouzourene H, Reimers M, Michetti P, et al. (2004) Inflammatory gene profiles in gastric mucosa during Helicobacter pylori infection in humans. J Immunol 172: 2595-2606.
23. Laurence J (2005) HIV and the lung in the HAART era. AIDS Read 15: 327, 330.
24. Nannini EC, Okhuysen PC (2002) HIV1 and the gut in the era of highly active antiretroviral therapy. Curr Gastroenterol Rep 4: 392-398.
25. Manzardo C, Del Mar Ortega M, Sued O, Garcia F, Moreno A, et al. (2005) Central nervous system opportunistic infections in developed countries in the highly active antiretroviral therapy era. J Neurovirol 11 Suppl 3: 72-82.
26. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, et al. (2006) Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 12: 1365-1371.
27. Bernasconi NL, Traggiai E, Lanzavecchia A (2002) Maintenance of serological memory by polyclonal activation of human memory B cells. Science 298: 2199-2202.
28. Zhou T, Xu L, Dey B, Hessell AJ, Van Ryk D, et al. (2007) Structural definition of a conserved neutralization epitope on HIV-1 gp120. Nature 445: 732-737.
29. Epeldegui M, Breen EC, Hung YP, Boscardin WJ, Detels R, et al. (2007) Elevated expression of activation induced cytidine deaminase in peripheral blood mononuclear cells precedes AIDS-NHL diagnosis. Aids 21: 2265-2270.
30. Hsu HC, Wu Y, Yang P, Wu Q, Job G, et al. (2007) Overexpression of activation-induced cytidine deaminase in B cells is associated with production of highly pathogenic autoantibodies. J Immunol 178: 5357-5365.
31. He B, Qiao X, Cerutti A (2004) CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10. J Immunol 173: 4479-4491.
32. Xu W, Santini PA, Matthews AJ, Chiu A, Plebani A, et al. (2008) Viral double-stranded RNA triggers Ig class switching by activating upper respiratory mucosa B cells through an innate TLR3 pathway involving BAFF. J Immunol 181: 276-287.
33. Frasca D, Riley RL, Blomberg BB (2007) Aging murine B cells have decreased class switch induced by anti-CD40 or BAFF. Exp Gerontol 42: 192-203.
34. Moir S, Ho J, Malaspina A, Wang W, DiPoto AC, et al. (2008) Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. J Exp Med 205: 1797-1805.
35. Chun TW, Carruth L, Finzi D, Shen X, DiGiuseppe JA, et al. (1997) Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387: 183-188.
36. Redgrave BE, Stone SF, French MA, Krueger R, James IR, et al. (2005) The effect of combination antiretroviral therapy on CD5 B- cells, B-cell activation and hypergammaglobulinaemia in HIV-1-infected patients. HIV Med 6: 307-312.
37. Cerutti A (2008) The regulation of IgA class switching. Nat Rev Immunol 8: 421-434.
38. Fagarasan S, Kinoshita K, Muramatsu M, Ikuta K, Honjo T (2001) In situ class switching and differentiation to IgA-producing cells in the gut lamina propria. Nature 413: 639-643.
39. Kato K, Chu P, Takahashi S, Hamada H, Kipps TJ (2007) Metalloprotease inhibitors block release of soluble CD27 and enhance the immune stimulatory activity of chronic lymphocytic leukemia cells. Exp Hematol 35: 434-442.
40. Sgadari C, Monini P, Barillari G, Ensoli B (2003) Use of HIV protease inhibitors to block Kaposi's sarcoma and tumour growth. Lancet Oncol 4: 537-547.
41. De Milito A, Aleman S, Marenzi R, Sonnerborg A, Fuchs D, et al. (2002) Plasma levels of soluble CD27: a simple marker to monitor immune activation during potent antiretroviral therapy in HIV-1-infected subjects. Clin Exp Immunol 127: 486-494.
42. Wei C, Anolik J, Cappione A, Zheng B, Pugh-Bernard A, et al. (2007) A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus. J Immunol 178: 6624-6633.
43. Fecteau JF, Cote G, Neron S (2006) A new memory CD27-IgG+ B cell population in peripheral blood expressing VH genes with low frequency of somatic mutation. J Immunol 177: 3728-3736.
44. Cagigi A, Mowafi F, Phuong Dang LV, Tenner-Racz K, Atlas A, et al. (2008) Altered expression of the receptor-ligand pair CXCR5/CXCL13 in B cells during chronic HIV-1 infection. Blood 112: 4401-4410.
45. Huggins J, Pellegrin T, Felgar RE, Wei C, Brown M, et al. (2007) CpG DNA activation and plasma-cell differentiation of CD27 - naive human B cells. Blood 109: 1611-1619.
46. Onlamoon N, Pattanapanyasat K, Ansari AA (2005) Human and nonhuman primate lentiviral infection and autoimmunity. Ann N Y Acad Sci 1050: 397-409.
47. Meyer-Bahlburg A, Rawlings DJ (2008) B cell autonomous TLR signaling and autoimmunity. Autoimmun Rev 7: 313-316.